The University of Colorado Anschutz Gates Institute Achieves First-in-U.S. FDA Clearance for Campus-Built CAR T-Cell Therapy

Novel treatment moves into first clinical trial for adults with hard-to-treat acute myeloid leukemia AURORA, Colo., April 2, 2026 /PRNewswire/ -- The University of Colorado Anschutz Gates Institute has received Investigational New Drug clearance from the U.S. Food and Drug Administration,...